Conditions: Diabetic Retinopathy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 731
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine if ruboxistaurin can help slow the worsening of an eye disease called macular edema in patients with diabetes.

Detailed description:

Arms:
arm 1: 32 milligrams (mg) once daily (QD) oral for up to 36 months arm 2: QD oral for up to 36 months

Interventions: intervention 1: ruboxistaurin intervention 2: placebo
Intervention descriptions: intervention 1: 32 mg once daily (QD) oral for up to 36 months intervention 2: QD oral for up to 36 months

Protocol document: